ALEXION PHARMACEUTICALS, INC. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2014 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | M | 10.84 | 30,000 | 325,200 | 0 | |
| Mar 13 2014 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | M | 8.18 | 30,000 | 245,400 | 0 | |
| Mar 13 2014 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Sell | S | 179.88 | 10,000 | 1,798,800 | 179,217 | 189.2 K to 179.2 K (-5.28 %) |
| Mar 13 2014 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Sell | S | 178.35 | 50,000 | 8,917,500 | 189,217 | 239.2 K to 189.2 K (-20.90 %) |
| Mar 13 2014 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Buy | M | 10.84 | 30,000 | 325,200 | 239,217 | 209.2 K to 239.2 K (+14.34 %) |
| Mar 13 2014 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Buy | M | 8.18 | 30,000 | 245,400 | 209,217 | 179.2 K to 209.2 K (+16.74 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Veneman Ann M | Director | Grant | A | 0.00 | 895 | 0 | 6,813 | 5.9 K to 6.8 K (+15.12 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 895 | 0 | 13,181 | 12.3 K to 13.2 K (+7.28 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 0.00 | 895 | 0 | 5,735 | 4.8 K to 5.7 K (+18.49 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 895 | 0 | 32,676 | 31.8 K to 32.7 K (+2.82 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Grant | A | 0.00 | 895 | 0 | 30,351 | 29.5 K to 30.4 K (+3.04 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Grant | A | 0.00 | 895 | 0 | 180,212 | 179.3 K to 180.2 K (+0.50 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | KELLER WILLIAM R | Director | Grant | A | 0.00 | 895 | 0 | 13,171 | 12.3 K to 13.2 K (+7.29 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Grant | A | 0.00 | 895 | 0 | 59,469 | 58.6 K to 59.5 K (+1.53 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | A | 176.80 | 36,900 | 6,523,920 | 36,900 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Grant | A | 0.00 | 2,300 | 0 | 24,532 | 22.2 K to 24.5 K (+10.35 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Option Exercise | A | 176.80 | 36,900 | 6,523,920 | 36,900 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Grant | A | 0.00 | 2,300 | 0 | 27,300 | 25 K to 27.3 K (+9.20 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Option Exercise | A | 176.80 | 36,900 | 6,523,920 | 36,900 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Sell | S | 174.77 | 305 | 53,305 | 16,760 | 17.1 K to 16.8 K (-1.79 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Grant | A | 0.00 | 3,300 | 0 | 17,065 | 13.8 K to 17.1 K (+23.97 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | A | 176.80 | 49,200 | 8,698,560 | 49,200 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 4,000 | 0 | 164,295 | 160.3 K to 164.3 K (+2.50 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | A | 176.80 | 49,200 | 8,698,560 | 49,200 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 3,000 | 0 | 28,000 | 25 K to 28 K (+12.00 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | A | 176.80 | 49,200 | 8,698,560 | 49,200 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,000 | 0 | 119,965 | 114 K to 120 K (+5.26 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Option Exercise | A | 176.80 | 49,200 | 8,698,560 | 49,200 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Grant | A | 0.00 | 4,000 | 0 | 108,606 | 104.6 K to 108.6 K (+3.82 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | A | 176.80 | 162,900 | 28,800,720 | 162,900 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 0.00 | 10,100 | 0 | 1,032,331 | 1 M to 1 M (+0.99 %) |